$PFE touched the bottom of the canal$PFE touched the bottom of the canal. Ready to come back to the top. Targets could be $39.8, $41.3 and $44-$46.
Stockmarkets
U.S. Patent Trial and Appeals Board Affirms ValidityU.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept’s U.S. Patent No.10,195,214
announced today that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued a decision upholding the validity of all claims of U.S. Patent No. 10,195,214, “Concomitant Administration of Glucocorticoid Receptor Modulators and CYP3A Inhibitors” (the “‘214 patent”). The ‘214 patent expires in 2037.
finance.yahoo.com
Successful field testing of prototype lines of the oilseedYield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
today announced successful field testing of prototype lines of the oilseed Camelina sativa that have been programed to produce PHA bioplastics directly in seed.
PHA are natural polymers, prevalent in nature and fully biodegradable in the environment.
PHA bioplastics could ultimately be used to manufacture a wide range of fully biodegradable consumer products.
The prototype plants tested in these studies were programed with microbial genes based on a recent patent filed for new technology developed by Yield10 researchers to produce Camelina seed containing high levels of PHA bioplastic suitable for field production.
finance.yahoo.com
Express, Inc. Announces $140 Million in Additional FinancingExpress, Inc. Announces $140 Million in Additional Financing to Bolster Liquidity
EXPR today announced that it has entered into a definitive loan agreement with Sycamore Partners as lead lender, along with Wells Fargo and Bank of America Merrill Lynch, that strengthens its liquidity position by an additional $140 million.
The new financing includes a $90 million FILO Term Loan with a maturity date of May 24, 2024, and a $50 million Delayed Draw Term Loan, to be repaid upon receipt of a CARES Act tax refund expected to be received in the second quarter of 2021.
This financing is in addition to the Company’s existing $250 million asset-based loan facility, of which it had previously drawn $165 million.
finance.yahoo.com
A 1 bill Val a 9$ price targetTwitter hyping: A 1 bill Val a 9$ price target by ARGUS research
twitter.com
GME Record Surge Gives Win to Reddit Army in Citron ClashGameStop Record Surge Gives Win to Reddit Army in Citron Clash
In the battle between short-seller Citron Research and an army of Reddit-charged day traders, GameStop Corp.’s seemingly endless rally to an all-time high has given the stock’s bulls a win, though not without controversy.
GameStop’s 75% gain through Friday comes after it more than doubled the week before and marks the most volatile 10-day period on record, data compiled by Bloomberg show. The stock was halted at least four times in New York as it surged as much as 79% to $76.76 as Reddit users ran wild. It was last 44% higher after trading resumed.
At one point, the video-game retailer was the most actively traded U.S. company with a market value above $200 million, data compiled by Bloomberg show, as millions of shares exchanged hands every few minutes.
GameStop representatives didn’t return an email seeking comment.
Reddit users continued to pump up their bets with one user saying they relied on it to pay their student loans.
GameStop’s parabolic rise, which has come amid steady and elevated short interest and increasing volume, has showcased the divide between retail bulls and bears betting on a quick return to reality.
GameStop became a “cult stock because of Ryan Cohen’s success with Chewy” and retail investors “appear confident that he can implement omnichannel initiatives that will materially grow their earnings,” Wedbush analyst Michael Pachter said in an email.
For the company to be worth $50 a share it would have to quickly double their growth, Pachter, who has a $16 price target which is the second highest among analyst tracked by Bloomberg, continued. In order to give GameStop credit for higher earnings power, Pachter, who rates the stock at neutral, wants to see Cohen’s strategy.
A backlash against Citron by some vocal Reddit users over its views on GameStop came to a head on Friday when the short seller said it will stop commenting on the stock following the actions of “an angry mob.”
“We are investors who put safety and family first and when we believe this has been compromised, it is our duty to walk away from a stock,” Citron managing partner Andrew Left wrote in a Friday letter.
The statement came a day after Left said in a YouTube video that he’d “never seen such an exchange of ideas of people so angry about someone joining the other side of a trade,” referring in part to Reddit users who have been particularly vocal on the social media site in seeking to promote their positive opinions on the video-game retailer’s stock.
GameStop fans clashed with Citron after the short seller critiqued shares in a tweet on Tuesday and made plans for a Twitter Inc. livestream the following day. The event was initially pushed back for the inauguration of President Joe Biden and then again on Thursday due to attempts to hack the short-seller’s Twitter account.
credited the bulk of last week’s gains to a short squeeze after activist investor and Chewy Inc. co-founder Ryan Cohen was added to GameStop’s board.
Bearish bets have remained steady with 140% of available GameStop shares currently sold short, according to data compiled by S3 Partners. Bears have seen more than $1.74 billion mark-to-market losses this year, according to the financial analytics firm.
“While older existing shorts have been covering some of their positions due to a profit-loss based short squeeze, there is a queue of new short sellers wanting to get short exposure in GME after its recent run-up,” Ihor Dusaniwsky, S3’s managing director of predictive analytics, said by email.
AzurRx BioPharma Announces First Two Patients DosedAzurRx BioPharma Announces First Two Patients Dosed in Phase 2b OPTION 2 Extension Study of MS1819 in Cystic Fibrosis Patients
Due to enrollment in the initial crossover trial being ahead of schedule, we are given an opportunity to thoroughly explore optimal doses and capsule types that will help guide our future development plans for MS1819 in a Phase 3 program. In the meantime, we will continue our preparation for a successful FDA meeting later this year.”
Topline data results for this study are anticipated in Q1 2021, as enrollment remains strong.
finance.yahoo.com
Termination of a Material Definitive AgreementInvestors appear to be responding to the company filing an 8-K today, which seems to indicate that there will be no dilution. This news went viral on a number of stock trading forums including StockTwits.
Termination of a Material Definitive Agreement.
On January 20, 2021, the Company delivered notice to Lincoln Park Capital Fund, LLC, an Illinois limited liability company (“Lincoln Park Capital”) terminating the Purchase Agreement, dated September 8, 2020 (the “2020 Purchase Agreement”), with Lincoln Park Capital effective January 21, 2021 (the “Termination Date”). The 2020 Purchase Agreement provided that, upon the terms and subject to the conditions and limitations set forth therein, the Company has the right to sell to Lincoln Park Capital up to $26 million of shares of the Company’s common stock, par value $0.01 per share (“Common Stock”), over the 36-month term of the 2020 Purchase Agreement. In consideration for entering into the 2020 Purchase Agreement, the Company issued to Lincoln Park Capital 437,828 shares of the Company’s Common Stock.
sec.report
pulse2.com
BBIG and ZASH Signing of Agreement to Complete Plan of mergerVinco Ventures (BBIG) and ZASH Announce Signing of Agreement to Complete Plan of Merger
Today announced the signing of an Agreement to Complete a Plan of Merger subject to certain conditions, creating exciting acceleration and growth in live-streaming content, video-sharing, distribution and production within its own ecosystem.
At the forefront of today’s digital wave, the Company aims to invest, acquire and merge the best-in-class media, entertainment and content-focused technology companies globally – from East to West – aiming to build a “Virtual Hollywood”, the future of media.
“The Company’s proprietary Influencer Platform has led to over 2 billion video views. With a current follower network of over 350+ million, we are poised to revolutionize the next generation of video distribution,” said Brian McFadden, Chief Strategy Officer.
Vinco’s Chief Strategy Officer, commented, “The merger with ZASH and the resulting combined entity provides current and prospective business partners with the assurance of our ability to scale our production and creative services to meet their growing content creation and distribution needs. The synergies between the two entities will bring immediate scale to the existing business along with clearly identified and obtainable growth initiatives. We are excited to merge with ZASH in our ever-evolving pursuit to ‘Be BIG’.”
www.streetinsider.com
Obalon Therapeutics Surges On News Of Merger With ReShape LifeObalon Therapeutics Surges 75% On News Of Merger With ReShape Lifesciences
ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering
ReShape Lifesciences, a weight-loss solutions company, entered into a merger agreement with Obalon Therapeutics, under which ReShape and Obalon will combine in an all-stock transaction.
Under the agreement, which has been unanimously approved by the boards of both companies, existing ReShape stockholders will have majority ownership of the combined company.
Obalon will be renamed ReShape Lifesciences Inc. and will trade under the NASDAQ ticker symbol "RSLS."
The current directors and officers of ReShape will comprise the board of directors and executive management of the combined company.
www.nasdaq.com
finance.yahoo.com
FTAC Olympus stock surges after Payoneer merger talks reportedPayoneer Inc., an online payments specialist, is in talks to go public through a merger with FTAC Olympus Acquisition Corp., a blank-check firm, according to people with knowledge of the matter.
The special purpose acquisition company has begun talks to raise new equity to support a transaction that’s slated to value the combined entity at more than $2.5 billion, said one of the people, who asked to not be identified because the matter isn’t public. As a deal isn’t finalized, it’s possible terms change or talks fall apart.
Representatives for New York-based Payoneer and FTAC declined to comment.
Founded in 2005, Payoneer -- which has said it’s profitable -- is backed by investors including Wellington Management Co., TCV, Greylock Partners, Ping An and Viola Ventures. The company, founded in Israel by Yuval Tal and now led by Chief Executive Officer Scott Galit, operates in more than 200 countries and territories. It provides services including cross-border payments for customers including Airbnb Inc., Amazon.com Inc., Google and Walmart Inc. its website shows.
FTAC, led by Chairman Betsy Cohen and Chief Executive Officer Ryan Gilbert, raised roughly $755 million in an August initial public offering for the purpose of acquiring or merging with a technology or financial services technology-focused company.
Read More: SoFi Plans for More Mergers After Going Public Through SPAC
Cohen is also chairman of blank-check firms FinTech Acquisition Corp. IV, which last month agreed to combine with Perella Weinberg Partners, and FinTech Acquisition Corp. V. She’s also chairman of FTAC Athena Acquisition Corp. which this week filed paperwork ahead of a targeted $220 million IPO and was the chairman of FinTech Acquisition Corp. III when it merged with payments company Paya Holdings Inc.
www.reddit.com
VANGUARD just invested with 2.6 mil sharesInuvo Prices $8.0 Million Common Stock Offering
has entered into a securities purchase agreement with institutional investors for the purchase and sale of 13,333,334 shares of its common stock, par value $0.001 per share, at a price of $0.60 per share, pursuant to a registered direct offering. The gross proceeds of the offering are expected to be $8.0 million before deducting fees and other estimated offering expenses. The closing of the registered direct offering is expected to take place on or about January 19, 2021, subject to the satisfaction of customary closing conditions.
finance.yahoo.com
AMC shares rose After $100M Secured-Debt IssuanceAMC Entertainment Jumps After $100M Secured-Debt Issuance
AMC issued $100 million in debt of five-year secured notes. to help finance operations through the pandemic.
In December the Leawood, Kan., company had secured a commitment for the debt financing from Mudrick Capital Management, the New York investment adviser.
Interest on the notes is 15% a year, payable in cash semiannually beginning July 15. For the first three interest periods after the issue date the company can choose payment-in-kind interest at a rate of 17% a year. After that interest must be paid in cash. The notes mature April 24, 2026.
Late last month, AMC filed with the SEC to offer as many as 50 million shares in an effort to avoid a bankruptcy filing.
That filing came on top of 200 million shares it filed for earlier in the month.
AMC has said it needs $750 million.
“And in the event of such future liquidation or bankruptcy proceeding, holders of our common stock and other securities would likely suffer a total loss of their investment,” it said in the filing.
www.thestreet.com
Tilman Fertitta Is in Talks to List Casino, Dining firm Via FSTTilman Fertitta Is in Talks to List Casino, Dining Assets Via SPAC
Texas billionaire and Houston Rockets owner Tilman Fertitta is in talks to take his casino and restaurant empire public through a merger with blank-check firm Fast Acquisition Corp., according to people with knowledge of the matter.
The special purpose acquisition company is in talks to raise more than $1 billion in new equity to support a transaction, said the people, who asked to not be identified because the matter isn’t public. The deal could value the combined entity at up to $7 billion including debt, one of the people added.
The new company, which Fertitta would still control, is set to include casinos and restaurants under the Golden Nugget and Landry’s umbrellas, they said. If talks are successful, a deal could be announced n the coming weeks. Terms may change and discussions could still fall apart.
Representatives for Golden Nugget and Fast Acquisition declined to comment.
finance.yahoo.com
Sorrento could surge 275% in 2021, Here is why...H.C. Wainwright analyst Ram Selvaraju rates SRNE a Buy along with a $30 price target, which implies a 275% upside from current levels.
Factors behind the optimistic outlook:
1. Sorrento has a stake in two cell-based immunotherapy companies that could “drive value in Sorrento shares over the coming months.”
2. the analyst highlights Sorrento’s “burgeoning portfolio of assets spanning three distinct therapeutic areas (non-opioid pain management, oncology and COVID-19).”.
3. two rapid COVID 19 detection tests; COVI-STIX, for which the company filed for Emergency Use Authorization (EUA) in the U.S. in December, and COVI-TRACE, which Selvaraju claims could come in handy at any mass gathering event.
“We believe that the incentive to facilitate the large-scale and indeed ubiquitous deployment of the COVI-TRACE test is extremely high and governments worldwide may seek to implement this in their respective regions,” the 5-star analyst opined.
4. Other Covid-19 candidates include COVIGUARD - a SARS-CoV-2 neutralizing antibody, COVI-AMG - an affinity-matured version of the COVIGUARD neutralizing antibody, a neutralizing antibody cocktail named COVI-SHIELD and COVIDTRAP, an ACE2 receptor decoy, intended to imitate the mammalian ACE2 receptor that acts as the primary portal for the SARS-CoV-2 virus to penetrate human cells.
finance.yahoo.com
Oppenheimer Analyst Says buy, following of some positive dataOppenheimer 5-star Analyst Says BioNano Genomics is ready to Execute in 2021.
the latest move was decidedly upbeat. In Wednesday’s session, the stock took off to the tune of 40% following the publication of some positive data.
article which made side-by-side comparisons between Bionano’s optical genome mapping platform Saphyr and PacBio's HiFi chemistry revealed that Saphyr had the upper hand on several metrics.
Across 32 different human genomes, PacBio technologies found only 72% of the large SVs (structural variants) that Bionano’s optical genome mapping (OGM) detected.
Saphyr was also found to be better at locating indels in regions correlated to neurodevelopment.
Additionally, Saphyr appears to be more cost effective. The platform’s estimated cost of $500 per genome coming in far below the $10,000-20,000 per genome when HiFi and SMRT sequencing are put into action.
Oppenheimer’s Kevin DeGeeter believes the data should help Saphyr make further inroads in the “large SV research market.” The analyst views 2021 “largely as an execution year.”
We expect the data to support broader adoption of Saphyr for de novo sequencing and research applications. the 5-star analyst said.
“Furthermore, we expect 2021 to be an important year for adoption of Saphyr for clinical cytogenetics market based on a series of positive recent publications... Based on our current assessment of the competitive landscape, we do not believe long-read sequencing technologies can replicate Saphyr's performance and cost structure for digital cytogenetics testing.”
Accordingly, DeGeeter reiterated an Outperform (i.e. Buy) on BNGO shares, along with a $1.5 price target. The implication for investors? Strong upside of 113% .
Two other analysts have thrown the hat in with a BNGO review recently, one saying Buy and the other recommending a Hold -- all add up to a Moderate Buy consensus rating. Meanwhile, the average price target stands at $1.42, implying gains of 101% could be in the cards over the next 12 months.
finance.yahoo.com
Owl Rock, Dyal Capital to go public via SPAC mergerOwl Rock and Dyal to combine to form Blue Owl, a differentiated alternative asset manager with industry leading Direct Lending and GP Capital Solutions businesses
Combined firm to manage over $45.0 billion in assets
Blue Owl to become publicly listed through a business combination with Altimar, a SPAC sponsored by an affiliate of HPS Investment Partners (NYSE:ATAC)
Blue Owl is expected to be listed on the NYSE under the ticker symbol "OWL" following the expected close of the transaction in the first half of 2021.
Transaction expected to provide approximately $1.8 billion in gross proceeds, comprised of Altimar’s $275 million of cash held in trust (assuming no redemptions) and a $1.5 billion fully committed, oversubscribed, common stock PIPE at $10.00 per share, including investments from ICONIQ Capital, CH Investment Partners, Koch Companies Defined Benefit Master Trust, the Federated Hermes Kaufmann Funds, and Liberty Mutual Investments
The founders and senior managers of Blue Owl will retain their equity stakes through the combined entity’s transition into a publicly listed company, promoting continued alignment.
The combined entity is expected to have a post-transaction market capitalization of approximately $12.5 billion.
finance.yahoo.com
BUY $MA - NRPicks Ene 17Mastercard is the second largest payment processor in the world and processed $4.8 billion in purchase transactions in 2019. Mastercard operates in over 200 countries and processes transactions in more than 150 currencies.
The COVID-19 has affected many companies and Mastercard has been no exception, however, it only reduced its sales by 10%. The company as well as its biggest competitors (Visa and Paypal) have developed and expanded their brand all over the world. Operationally the company maintains an average level of debt compared to its competitors and will have no problem meeting its financial obligations.
Fundamentals:
- Growth
- 18.7% estimated growth in net earnings for the next 3 years
- ROE 255% VS 13.6% industry
Technicians:
- Price level below SMA 250-200-150
- Williams R% at -89% levels
- RSI (24) Overbooking
-8% average upside during the month
A correction of 9% was presented from December 8 to January 15, which stopped at a support of $322. At this point, we expect the stock to show a change in trend as the 322 level has been respected several times during the year. Finally, Technical Indicators like SMA, Williams R% and RSI show us buy opportunity.
BlackBerry sold 90 smartphone technology patents to HuaweiShares of BlackBerry (NYSE:BB) soared Thursday despite an apparent lack of company-specific news. Investors may have been responding to a report published earlier this week that said the company sold some of its patents to Huawei.
Canadian newspaper The Globe and Mail reported Tuesday that BlackBerry had sold 90 smartphone technology patents to the Chinese technology giant Huawei.
BlackBerry stopped manufacturing smartphones back in 2016, but the company still has a large number of patents relating to those devices. Selling some of them is yet another clear sign that it has moved on and is putting its efforts into other businesses.
investors may be continuing to express their positive sentiment toward the tech stock, which is up more than 100% over the past six months.
www.fool.com
CHRA Awarded Large-Scale, 12-Year Ash Marketing ContractCharah Solutions Awarded Large-Scale, 12-Year Ash Marketing Contract by Dominion Energy for Beneficial Use of 8.1 Million Tons of Reclaimed Ponded Coal Ash
For the beneficiation and utilization of up to 8.1 million tons of reclaimed ponded coal ash at its Chesterfield Power Station in Chester, VA. Dominion Energy is headquartered in Richmond, VA.
As part of the agreement, Charah Solutions will install processing and transportation infrastructure in 2021 to facilitate rail transportation of the ash from Chesterfield Power Station to cement kiln feed markets.
finance.yahoo.com
TOASO BOĞA TRENDİ BAŞLIYORÖnemli bir direnç noktası kırıldıktan sonra düzeltme yapan bu kağıt önemli bir boğa trendinin başlangıcında.
Datasea to Focus on the 5G OpportunitiesDatasea Announces the Establishment of a New Company to Focus on the 5G Opportunities and Related Value-added Services
Our technology shares a particular connection with 5G messaging known as Rich Communication Services ("RCS"), which enables us to develop services related to 5G messaging. The 5G messaging involves customer-to-customer interactions and enhances traditional messaging services with new services such as multimedia messaging, commercial messaging and interactive services.
finance.yahoo.com
Facebook - investment stock ideaFacebook is a company that needs no introduction. Against the backdrop of negative news, there was a fall, but now the price has reached the daily resistance + the strongest deviation from almost all TFs up to 12h. Also, the news background is already improving.
The probability of further falling is extremely low, besides there is a reaction from the support zone.
Entrance zone 245-250.
Cancellation of the scenario - price go below 235.
Potential profit 4-8% minimum.
Investment for at least 2-3 weeks.
Operations in financial markets can bring both large potential profits and are associated with potential risks associated, among other things, with the effect of leverage and high volatility of instruments used in trading in financial markets.
The provided forecast is a subjective analytical assessment of the situation in the financial market and in no way is it a recommendation for opening deals, investing and developing your own trading strategy.
